Abbott Settles TriCor Class Action For $184M
After several years of hard-fought litigation, Abbott Laboratories has agreed to pay $184 million to settle antitrust claims by rival pharmaceutical companies, drug stores and other purchasers that the company profited...To view the full article, register now.
Already a subscriber? Click here to view full article